Long-Term Effects of a Stepwise, Multimodal, Non-Restrictive Antimicrobial Stewardship Programme for Reducing

Mar Ronda1, Victor Daniel Gumucio-Sanguino2,3, Evelyn Shaw1,3,4

  • 1Department of Infectious Diseases, Hospital Universitari de Bellvitge, Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.

PubMed

Insights

A stepwise, non-restrictive antimicrobial stewardship (AMS) program in the ICU reduced broad-spectrum antibiotic use and improved prescribing appropriateness over eight years. This study offers insights into long-term AMS strategy effects.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Public Health

Background:

  • Limited data exists on the long-term impact of non-restrictive antimicrobial stewardship (AMS) strategies.
  • Intensive care units (ICUs) are critical settings for monitoring antibiotic use due to high consumption and resistance risks.
  • Evaluating sustained effects of AMS programs is essential for optimizing antibiotic use and combating antimicrobial resistance.

Purpose of the Study:

  • To assess the long-term effects of a stepwise, multimodal, non-restrictive AMS program on antibiotic use in the ICU.
  • To evaluate the impact of the AMS program on broad-spectrum antibiotic consumption.
  • To determine changes in the appropriateness of antibiotic prescribing over an eight-year period.

Main Methods:

  • A prospective, 8-year study (2011-2019) involving a stepwise implementation of a non-restrictive AMS program in an ICU.
  • Antibiotic use was measured in DDD per 100 patient-days (PD).
  • Monthly point-prevalence surveys assessed antibiotic prescribing appropriateness; Poisson regression analyzed trends.

Main Results:

  • Overall antibiotic use decreased by 23% (from 185.4 to 141.9 DDD/100 PD).
  • Broad-spectrum antibiotic use showed an initial increase followed by a sustained 10% annual reduction post-2016.
  • Appropriateness of antibiotic prescribing significantly improved, increasing by 11% annually (p=0.048).

Conclusions:

  • A stepwise, multimodal, non-restrictive AMS program can achieve sustained reductions in broad-spectrum antibiotic use in ICUs.
  • The implemented AMS strategy significantly improved the appropriateness of antibiotic prescribing over the long term.
  • This approach provides a viable model for optimizing antibiotic use in critical care settings without restrictive measures.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.9K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
327
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
403
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.2K